Lora L. Pike
Keine laufenden Positionen mehr
Profil
Lora L.
Pike worked as an Associate Director of Investor Relations at Vertex Pharmaceuticals, Inc. in 2009.
She then worked as a Senior Director of Investor Relations at Keryx Biopharmaceuticals, Inc., Momenta Pharmaceuticals, Inc., and Agios Pharmaceuticals, Inc.
Ehemalige bekannte Positionen von Lora L. Pike
| Unternehmen | Position | Ende |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Investor Relations Kontakt | 12.12.2018 |
| MOMENTA PHARMACEUTICALS, INC. | Investor Relations Kontakt | - |
| AGIOS PHARMACEUTICALS, INC. | Investor Relations Kontakt | - |
| VERTEX PHARMACEUTICALS INCORPORATED | Public Communications Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
